| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Interim Chief Financial Officer & Controller | Common Stock | 44,349 | $10,112 | $0.2280 | 01 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 01 Jan 2025 | 1 | $0 | 4 | Interim Chief Financial Officer & Controller | 03 Jan 2025, 17:33 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 11 Mar 2024 | 1 | $0 | 4 | Interim Chief Financial Officer & Controller | 13 Mar 2024, 20:55 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 25 Aug 2021 | 0 | $0 | 3 | Interim Chief Financial Officer Exhibit 24-Power of Attorney | 02 Sep 2021, 16:01 |